Ex parte MERUELO et al. - Page 2




                Appeal No. 95-4441                                                                                                       
                Application No. 07/970,229                                                                                               


                        This is a decision on an appeal from the final rejection                                                         
                of claims 13 through 27 which are all of the claims remaining                                                            
                in the application.  On page 2 of the Brief, the appellants                                                              
                have indicated that claims 16 and 24 are withdrawn from this                                                             
                appeal, thereby leaving for our consideration only claims 13                                                             
                through 15, 17 through 23 and 25 through 27 .                        2                                                   
                        The subject matter on appeal relates to a method for                                                             
                treating a mammal suffering from a viral infection comprising                                                            
                administering to the mammal a virus inhibiting amount of                                                                 
                certain compounds.  This appealed subject matter also relates                                                            
                to a pharmaceutical composition for treating mammals suffering                                                           
                from viral infections comprising a pharmaceutically acceptable                                                           
                carrier or diluent in combination with an antiviral effective                                                            


                        2Contrary to the appellants’ impression, claims 17, 21                                                           
                and 25 do not read in the manner reflected by the claim                                                                  
                reproductions which appear in the appendix of the Brief.                                                                 
                                                                                       7         8                                       
                Specifically, claims 17 and 25 recite that R  and R  are H                                                               
                rather than OH as reproduced in view of the amendment filed                                                              
                April 8, 1993.  Additionally, line 4 of claim 21 recites                                                                 
                “effect amount” rather than --effective amount-- as                                                                      
                reproduced.  In our disposition of this appeal, we will treat                                                            
                the aforementioned claims as though they contain the language                                                            
                desired by the appellants as shown in the Brief appendix.                                                                
                However, in any further prosecution that may occur, the                                                                  
                appellants should amend these claims to that they contain the                                                            
                desired language.                                                                                                        
                                                                   2                                                                     





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007